Calcitriol Capsule — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Calcitriol Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 12/04/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0093-7353-01
Dosage Form
Capsule
Presentation
Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)
Initial Posting
12/04/2025
Revised Date